Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Grady

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Molecular and Biochemical Parasitology|April 11, 1991
Mitochondrial development in Trypanosoma brucei brucei transitional bloodstream formsE J Bienen, M Saric, G Pollakis, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1978
The development of new iron-chelating drugs. IIR W Grady, J H Graziano, G P White, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1980
Thrombocytosis in the offspring of female mice receiving DL-methadoneY Burstein, R W Grady, M J Kreek, et al.
Lancet (London, England)|September 6, 2000
Deferiprone for thalassaemiaG J Kontoghiorghes, M B Agarwal, R W Grady, et al.
Blood|November 1, 1989
Antimalarial effect of HBED and other phenolic and catecholic iron chelatorsA M Yinnon, E N Theanacho, R W Grady, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
N-n-alkyl-3,4-dihydroxybenzamides as inhibitors of the trypanosome alternative oxidase: activity in vitro and in vivoR W Grady, E J Bienen, H A Dieck, et al.
Archives of Biochemistry and Biophysics|September 1, 1988
The influence of heme-binding proteins in heme-catalyzed oxidationsS H Vincent, R W Grady, N Shaklai, et al.
Harefuah|November 16, 1986
[Hemochromatosis and iron chelating therapy]C Hershko, A G Link, A Pinson, et al.
Annals of the New York Academy of Sciences|January 1, 1985
The effect of subcutaneous deferoxamine on the cardiac profile of thalassemia major: a five-year studyP J Giardina, K H Ehlers, M A Engle, et al.
Blood|January 1, 1992
Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron storesS Zevin, G Link, R W Grady, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Molecular and Biochemical Parasitology|April 11, 1991
Mitochondrial development in Trypanosoma brucei brucei transitional bloodstream formsE J Bienen, M Saric, G Pollakis, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1978
The development of new iron-chelating drugs. IIR W Grady, J H Graziano, G P White, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1980
Thrombocytosis in the offspring of female mice receiving DL-methadoneY Burstein, R W Grady, M J Kreek, et al.
Lancet (London, England)|September 6, 2000
Deferiprone for thalassaemiaG J Kontoghiorghes, M B Agarwal, R W Grady, et al.
Blood|November 1, 1989
Antimalarial effect of HBED and other phenolic and catecholic iron chelatorsA M Yinnon, E N Theanacho, R W Grady, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
N-n-alkyl-3,4-dihydroxybenzamides as inhibitors of the trypanosome alternative oxidase: activity in vitro and in vivoR W Grady, E J Bienen, H A Dieck, et al.
Archives of Biochemistry and Biophysics|September 1, 1988
The influence of heme-binding proteins in heme-catalyzed oxidationsS H Vincent, R W Grady, N Shaklai, et al.
Harefuah|November 16, 1986
[Hemochromatosis and iron chelating therapy]C Hershko, A G Link, A Pinson, et al.
Annals of the New York Academy of Sciences|January 1, 1985
The effect of subcutaneous deferoxamine on the cardiac profile of thalassemia major: a five-year studyP J Giardina, K H Ehlers, M A Engle, et al.
Blood|January 1, 1992
Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron storesS Zevin, G Link, R W Grady, et al.
Pageof 9